Connect Biopharma Holdings Ltd (CNTB) stock
CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58−0.06 (-9.98%)
Close on Nov 17, 2026Market cap $36.45MP/E –Yield –
Connect Biopharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Connect Biopharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$60.58M. For fiscal 2025 it was -$51.21M. The highest annual figure on record is -$23.61M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$51.21M | – |
| FY2024 | Dec 31, 2024 | -$23.61M | – |
| FY2023 | Dec 31, 2023 | -$47.74M | – |
| FY2022 | Dec 31, 2022 | -$101.52M | – |
| FY2021 | Dec 31, 2021 | -$84.32M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.01M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.25M | – |
| Q3 FY2025 | Sep 30, 2025 | -$17.41M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.59M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.96M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.32M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.01M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.70M | – |
| Q1 FY2024 | Mar 31, 2024 | -$591.00K | – |
See a number that looks wrong?